A phase 1b, multi-arm, open-label, study of HDM201 in combination with MBG453 or venetoclax in adult subjects with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS).
- Wei, Andrew (Primary Chief Investigator (PCI))
- Kennedy, Nola (Chief Investigator (CI))
Project: Research